ADVIA Centaur¿ PSA Assay; Cat No. 06574155/SMN 10310292 (100 test)/02676506/SMN 10310293 (500 test)
Class I - DangerousWhat Should You Do?
- Check if you have this product: SMN 10310292 - 100 test kits Lot# UDI# 40776268 0063041420300340776268160922 53535268 0063041420300353535268160922 67015269 0063041420300367015269161124 72335269 00630414203003723352691611 24 82156270 0063041420300382156270161229 87504270 0063041420300387504270161229 93298271 0063041420300393298271170205 5702271 0063041420300305702271170205 17339271 006304142030031733927 11 70205 19110272 0063041420300319110272170418 27655272 0063041420300327655272170418 SMN 10310293- 500 test kits Lot# 39805268 50851268 60225269 71544269 81085270 86551270 93505271 7329271 16252272 24689272 33327272 UDI# 0063041420299039805268160922 0063041420299050851268160922 0063041420299060225269161124 0063041420299071544269161124 0063041420299081085270161229 0063041 420299086551270161229 0063041 420299093505271 170205 0063041420299007329271 170205 0063041420299016252272170418 0063041420299024689272170418 0063041420299033327272170418
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Siemens Healthcare Diagnostics, Inc
- Reason for Recall:
- Communication provided to emphasize that the PSA values should be interpreted in accordance with current clinical guidelines for defining biochemical recurrence following radical prostatectomy.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
ADVIA Centaur¿ PSA Assay; Cat No. 06574155/SMN 10310292 (100 test)/02676506/SMN 10310293 (500 test)
Product Codes/Lot Numbers:
SMN 10310292 - 100 test kits Lot# UDI# 40776268 0063041420300340776268160922 53535268 0063041420300353535268160922 67015269 0063041420300367015269161124 72335269 00630414203003723352691611 24 82156270 0063041420300382156270161229 87504270 0063041420300387504270161229 93298271 0063041420300393298271170205 5702271 0063041420300305702271170205 17339271 006304142030031733927 11 70205 19110272 0063041420300319110272170418 27655272 0063041420300327655272170418 SMN 10310293- 500 test kits Lot# 39805268 50851268 60225269 71544269 81085270 86551270 93505271 7329271 16252272 24689272 33327272 UDI# 0063041420299039805268160922 0063041420299050851268160922 0063041420299060225269161124 0063041420299071544269161124 0063041420299081085270161229 0063041 420299086551270161229 0063041 420299093505271 170205 0063041420299007329271 170205 0063041420299016252272170418 0063041420299024689272170418 0063041420299033327272170418
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-2742-2016
Related Recalls
Siemens Dimension Tacrolimus Flex Reagent Cartridge (TAC), REF DF207, SMN 10700795; enzyme immunoassay
Siemens Healthcare Diagnostics
A potential positive bias in quality control (QC) and patient sample results in three lots of the Dimension Tacrolimus (TAC) Flex reagent cartridge.
Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.
Siemens Healthcare Diagnostics
Siemens Healthcare Diagnostics is recalling certain lots of Dimension Creatinine Flex reagent cartridge (Dimension CRE2) because a potential imprecision in the Dimension CRE2 quality control (QC) and patient sample results using lot numbers GA6307 and BA7005 on the Dimension System. This imprecision may lead to erroneously decreased or increased creatinine patient results
Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;
Siemens Healthcare Diagnostics
A potential for depressed results for Atellica CH A1c_E when processing Atellica CH RCRP on the same analyzer. Customers processing A1c_E and RCRP on separate analyzers are not impacted by the recall. The frequency and magnitude of the negative bias and imprecision increase over time and are not consistent with the assay Instructions For Use (IFU). When this issue is present, Quality Control (QC) results demonstrate a negative trend and increased imprecision. The clinical impact of a negative (A1c_E) bias may lead to a delay in diagnosis for diabetes or lead to less-than-optimal treatment for existing diabetes.